Completed PHASE2 INTERVENTIONAL 5-arm NCT01483963

AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder

A Phase 2a, Open-label, Dose-ranging Study of the Safety and Effectiveness of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder

Sponsor: Endo Pharmaceuticals

Conditions Adhesive Capsulitis Frozen Shoulder

Interventions AA4500 0.29 mg/1 mL AA4500 0.58 mg/0.5 mL AA4500 0.58 mg/1 mL AA4500 0.58 mg/2 mL Shoulder exercises

Updated 9 times since 2017 Last updated: Sep 7, 2017 Started: Nov 30, 2011 Primary completion: Feb 28, 2013 Completion: Feb 28, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Adhesive Capsulitis and Frozen Shoulder, this trial is completed. The trial is conducted by Endo Pharmaceuticals and has accumulated 9 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2
Jan 2021 — Dec 2022 [monthly]

Completed PHASE2

▶ Show 4 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jul 2017 — Jun 2018 [monthly]

Completed PHASE2
Feb 2017 — Jul 2017 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Nov 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Endo Pharmaceuticals

Data source: Endo Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Altoona, United States , Birmingham, United States , Clarksville, United States , Cleveland, United States , Encinitas, United States , Indianapolis, United States , La Mesa, United States , Little Rock, United States , Odessa, United States , Oklahoma City, United States and 5 more locations